Altogether, our results indicate that in obese mice bearing HCC, loss of PI3Kγ activity does not affect apoptosis or AKT phosphorylation in tumours but reduces ERK signalling, cyclin D1 expression, and tumour cell proliferation. Here, AKT1 is linked to hepatocellular carcinoma.